CPMP konkluderede, at der i afsnit 4. 2 i produktresuméet burde være en angivelse af, at behandlingens varighed bør holdes på så kort et tidsrum som muligt og ikke bør fortsætte efter, at symptomerne er forsvundet.
The CPMP concluded that a statement stating that the duration of treatment should be kept as short as possible and should not be continued after the symptoms have disappeared, should be given in section 4.2 of the SPC.